These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

147 related articles for article (PubMed ID: 3059929)

  • 1. Neuropeptides, dopamine, and schizophrenia.
    Nemeroff CB; Bissette G
    Ann N Y Acad Sci; 1988; 537():273-91. PubMed ID: 3059929
    [No Abstract]   [Full Text] [Related]  

  • 2. Endorphins, dopamine, and schizophrenia.
    Volavka J; Davis LG; Ehrlich YH
    Schizophr Bull; 1979; 5(2):227-39. PubMed ID: 37595
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Neuropeptides and schizophrenia.
    Bissette G; Nemeroff CB; MacKay AV
    Prog Brain Res; 1986; 66():161-74. PubMed ID: 3538166
    [No Abstract]   [Full Text] [Related]  

  • 4. Endorphin hypothesis of schizophrenia.
    Wahlström A; Terenius L
    Mod Probl Pharmacopsychiatry; 1981; 17():181-91. PubMed ID: 6276723
    [No Abstract]   [Full Text] [Related]  

  • 5. Dopamine supersensitivity, endorphin excess, and prostaglandin E1 deficiency: three aspects of the same schizophrenic elephant.
    Horrobin DF
    Schizophr Bull; 1978; 4(4):487-8. PubMed ID: 734362
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Mental disorders and neuropeptides].
    Moroji T; Katsuura G
    Nihon Rinsho; 1990 May; 48(5):1077-83. PubMed ID: 1973953
    [No Abstract]   [Full Text] [Related]  

  • 7. Neuropeptide systems and schizophrenia.
    LaCrosse AL; Olive MF
    CNS Neurol Disord Drug Targets; 2013 Aug; 12(5):619-32. PubMed ID: 23574175
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The use of the synthetic peptides gamma-type endorphins in mentally ill patients.
    van Ree JM; Verhoeven WM; de Wied D; van Praag HM
    Ann N Y Acad Sci; 1982; 398():478-95. PubMed ID: 6186176
    [No Abstract]   [Full Text] [Related]  

  • 9. [Neurochemical and structural changes in schizophrenia--correlation with the clinical picture].
    Gamito AO
    Acta Med Port; 1990; 3(2):123-5. PubMed ID: 2190444
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Biochemistry and the schizophrenia. Old concepts and new hypothesis.
    Berger PA
    J Nerv Ment Dis; 1981 Feb; 169(2):90-9. PubMed ID: 7009786
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Psychopharmacology and endorphins].
    Langwiński R
    Psychiatr Pol; 1979; 13(6):533-42. PubMed ID: 531127
    [No Abstract]   [Full Text] [Related]  

  • 12. Chemical brain anatomy in schizophrenia.
    Sedvall G; Farde L
    Lancet; 1995 Sep; 346(8977):743-9. PubMed ID: 7658878
    [No Abstract]   [Full Text] [Related]  

  • 13. Clinical pharmacology of beta-endorphin in depression and schizophrenia.
    Catlin DH; Gorelick DA; Gerner RH
    Ann N Y Acad Sci; 1982; 398():434-47. PubMed ID: 6297363
    [No Abstract]   [Full Text] [Related]  

  • 14. [Biological determinants of schizophrenic psychoses].
    Verhoeven WM; Westenberg HG; Van Ree JM
    Encephale; 1984; 10(2):53-68. PubMed ID: 6088215
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Neuropeptides and oligopeptidases in schizophrenia.
    Rodríguez B; Nani JV; Almeida PGC; Brietzke E; Lee RS; Hayashi MAF
    Neurosci Biobehav Rev; 2020 Jan; 108():679-693. PubMed ID: 31794779
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Stress, endorphins and psychosis. A hypothesis.
    Amir S; Amit Z; Brown ZW
    Mod Probl Pharmacopsychiatry; 1981; 17():192-201. PubMed ID: 6276725
    [No Abstract]   [Full Text] [Related]  

  • 17. [Antipsychotic efficacy of neuroleptic neuropeptides in schizophrenia. Review of clinical data].
    Verhoeven VM
    Encephale; 1987; 13(6):349-56. PubMed ID: 2453339
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Endorphins in psychiatry].
    Lajeunesse C; Villeneuve A
    Sem Hop; 1982 Dec; 58(44):2581-7. PubMed ID: 6297051
    [No Abstract]   [Full Text] [Related]  

  • 19. Central dopaminergic mechanisms in schizophrenia.
    Owen F; Crow TJ; Poulter M
    Acta Psychiatr Belg; 1987; 87(5):552-65. PubMed ID: 2897760
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Abnormalities in the dopamine system in schizophrenia may lie in altered levels of dopamine receptor-interacting proteins.
    Bai J; He F; Novikova SI; Undie AS; Dracheva S; Haroutunian V; Lidow MS
    Biol Psychiatry; 2004 Sep; 56(6):427-40. PubMed ID: 15364041
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.